Painreform Ebitda from 2010 to 2024

PRFX Stock  USD 2.97  0.23  7.19%   
Painreform EBITDA yearly trend continues to be fairly stable with very little volatility. EBITDA is likely to outpace its year average in 2024. During the period from 2010 to 2024, Painreform EBITDA regression line of annual values had significance of  0.0003 and arithmetic mean of (2,775,370). View All Fundamentals
 
EBITDA  
First Reported
2017-12-31
Previous Quarter
-5.6 M
Current Value
-7.3 M
Quarterly Volatility
1.8 M
 
Covid
Check Painreform financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Painreform's main balance sheet or income statement drivers, such as Interest Expense of 362.5 K, Tax Provision of 7.6 K or Depreciation And Amortization of 18.1 K, as well as many indicators such as Price To Sales Ratio of 982, Dividend Yield of 0.0 or PTB Ratio of 2.09. Painreform financial statements analysis is a perfect complement when working with Painreform Valuation or Volatility modules.
  
Check out the analysis of Painreform Correlation against competitors.
For more information on how to buy Painreform Stock please use our How to Invest in Painreform guide.

Latest Painreform's Ebitda Growth Pattern

Below is the plot of the Ebitda of Painreform over the last few years. It is Painreform's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Painreform's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Painreform Ebitda Regression Statistics

Arithmetic Mean(2,775,370)
Coefficient Of Variation(134.30)
Mean Deviation3,148,409
Median(501,000)
Standard Deviation3,727,336
Sample Variance13.9T
Range9.1M
R-Value(0.80)
Mean Square Error5.3T
R-Squared0.64
Significance0.0003
Slope(668,139)
Total Sum of Squares194.5T

Painreform Ebitda History

2024-9.1 M
2023-9.6 M
2022-8.9 M
2021-7.2 M
2020-1.7 M
2019-737 K

About Painreform Financial Statements

Painreform investors use historical fundamental indicators, such as Painreform's Ebitda, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Painreform. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA-9.6 M-9.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Painreform Stock Analysis

When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.